Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

- PMLiVE

Amgen’s Humira biosimilars backed for EU approval

Amgevita and Solymbic prepare to challenge AbbVie’s blockbuster

- PMLiVE

Ashfield to establish European MSL network for Diurnal’s Infacort

Hormone replacement drug anticipated to receive EU approval later this year

The rating game

Have we gone too far with online healthcare reviews?

- PMLiVE

Lilly pilots enhanced online trial information

Company aims to aid comprehension of the informed consent process

- PMLiVE

2017 Trends Reports

GSW and InVentiv Health Communications are pleased to release the 6th installment of the Trends report series, consisting of four reports: Consumer, Digital, Communications and Healthcare

Syneos Health®

Bristol-Myers Squibb (BMS) building

Opdivo drives growth at BMS, but US sales slow down

Sales beginning to lose momentum despite new indications bringing in $1.3bn for Q4

- PMLiVE

NICE U-turn on Imbruvica sees the leukaemia therapy backed for NHS use

Institute reverses its initial verdict on Janssen's oncology treatment

Celgene building

Celgene pays $300m upfront for immunology start-up Delinia

Broadens its pipeline with autoimmune disease candidate due to start trials in 2018

- PMLiVE

The reality of real-world evidence

Despite a slow uptake of RWE, there is an increasing trend in the use of healthcare system data to inform clinical practice

- PMLiVE

AXON Communications boosts senior team

Sola Neunie, Simonetta Ballali and Andy Scott join

- PMLiVE

Takeda UK & Ireland appoints market access director

Peter Wheatley Price brings experience from GSK, Janssen and Boehringer Ingelheim

- PMLiVE

AbbVie takes anti-tau drug into phase II for Alzheimer’s

Also testing antibody in rare condition PSP, for which FDA has awarded fast-track designation

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links